GM-CSF in Patients With Pulmonary Alveolar Proteinosis
NCT00030056 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2015-03-25
Summary
This is a study to determine the efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF, sargramostim) administered subcutaneously to patients with pulmonary alveolar proteinosis (PAP).
Conditions
- Pulmonary Alveolar Proteinosis
Interventions
- DRUG
-
GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-30
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Mycophenolate for Pulmonary Sarcoidosis
NCT00262132 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
NCT06962800 ·Status: RECRUITING ·Phase: PHASE3
-
Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
NCT02592798 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
NCT05809531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Prospective Study on Optimizing Treatment for ABPA
NCT05129033 ·Status: UNKNOWN ·Phase: NA
-
GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study
NCT03769844 ·Status: COMPLETED ·Phase: PHASE4
-
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
NCT02556866 ·Status: TERMINATED ·Phase: PHASE2
-
The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis
NCT03531996 ·Status: COMPLETED
-
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
NCT04871191 ·Status: RECRUITING ·Phase: PHASE3
-
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
NCT06868290 ·Status: RECRUITING ·Phase: PHASE2
-
Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001155 ·Status: COMPLETED ·Phase: PHASE2
-
SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study
NCT02840708 ·Status: COMPLETED ·Phase: PHASE1
-
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
NCT05623592 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
NCT02108860 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides
NCT00001473 ·Status: COMPLETED
-
Steroids and Methotrexate to Treat Systemic Vasculitis
NCT00001256 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.
NCT03290456 ·Status: RECRUITING ·Phase: NA
-
Tocilizumab Plus a Short Prednisone Taper for GCA
NCT03726749 ·Status: COMPLETED ·Phase: PHASE4
-
Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
NCT00647166 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen
NCT03009708 ·Status: COMPLETED ·Phase: NA
-
Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
NCT04031066 ·Status: WITHDRAWN ·Phase: PHASE3
-
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia
NCT02544230 ·Status: COMPLETED
-
Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Refractory Asthma
NCT00888472 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Rituximab in Eosinophilic Granulomatosis With Polyangiitis
NCT02807103 ·Status: COMPLETED ·Phase: PHASE3